middle.news
LTR Pharma’s SPONTAN Shows Strong Real-World Response in Post-Prostatectomy and Convenience-Seeking Men
8:32am on Tuesday 11th of August, 2026 AEST
•
Healthcare
Read Story
LTR Pharma’s SPONTAN Shows Strong Real-World Response in Post-Prostatectomy and Convenience-Seeking Men
8:32am on Tuesday 11th of August, 2026 AEST
Key Points
93% response in convenience-seeking men
64% response in post-prostatectomy patients
57% response in men with prior inadequate oral ED therapy
68% overall cohort response rate
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE